Thyroid Function Test Market Size & Share, by Type (TSH Test, T4 Test, T3 Test); End-user (Diagnostic Laboratories, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4797
  • Published Date: Apr 08, 2023
  • Report Format: PDF, PPT

Companies Dominating the Thyroid Function Test Landscape

top-features-companies
    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Quest Diagnostics
    • Eli Lilly and Company
    • Autobio Diagnostics Co., Ltd.
    • BioMérieux SA
    • Danaher Corporation
    • DiaSorin S,p.A.
    • F. Hoffmann-La Roche Ltd.
    • Qualigen Therapeutics Inc.
    • Thermo Fisher Scientific Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Eli Lilly and Company announced the approval of U.S Food and Drug Administration (FDA) for Retevmo the first medicine particularly approved for the treatment of adult patients with metastatic RET-mutant medullary thyroid cancer. Approval based on results from the largest patient trial yet reported in RET-driven malignancies, LIBRETTO-001 Phase 1/2

  • Quest Diagnostics introduces the very first virtual preventive care service through QuestDirect that is customizable for men and women and gives a health quotient score that can be monitored over time. It uses biometric screening and does a health risk assessment.

 


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4797
  • Published Date: Apr 08, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of thyroid diseases and thyroid cancer, sedentary lifestyle of people, and growing intake of alcohol are the major factors driving the market growth.

The market size of thyroid function test is anticipated to attain a CAGR of 8.9% over the forecast period, i.e., 2023-2035.

Shortage of endocrinologists, and difficulty in reading blood tests for thyroid are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Abbott, Autobio Diagnostics Co., Ltd., BioMérieux SA, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Qualigen Therapeutics Inc., Thermo Fisher Scientific Inc., Quest Diagnostics, and Eli Lilly and Company

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, end user, and by region.

The TSH test segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying